共查询到20条相似文献,搜索用时 31 毫秒
1.
Lars Neumann Allegra Ritscher Gerhard Müller Doris Hafenbradl 《Journal of computer-aided molecular design》2009,23(8):501-511
For the detection of the precise and unambiguous binding of fragments to a specific binding site on the target protein, we
have developed a novel reporter displacement binding assay technology. The application of this technology for the fragment
screening as well as the fragment evolution process with a specific modelling based design strategy is demonstrated for inhibitors
of the protein kinase p38alpha. In a fragment screening approach seed fragments were identified which were then used to build
compounds from the deep-pocket towards the hinge binding area of the protein kinase p38alpha based on a modelling approach.
BIRB796 was used as a blueprint for the alignment of the fragments. The fragment evolution of these deep-pocket binding fragments
towards the fully optimized inhibitor BIRB796 included the modulation of the residence time as well as the affinity. The goal
of our study was to evaluate the robustness and efficiency of our novel fragment screening technology at high fragment concentrations,
compare the screening data with biochemical activity data and to demonstrate the evolution of the hit fragments with fast
kinetics, into slow kinetic inhibitors in an in silico approach. 相似文献
2.
Hoffer L Renaud JP Horvath D 《Combinatorial chemistry & high throughput screening》2011,14(6):500-520
Fragment-based screening is an emerging technology which is used as an alternative to high-throughput screening (HTS), and often in parallel. Fragment screening focuses on very small compounds. Because of their small size and simplicity, fragments exhibit a low to medium binding affinity (mM to μM) and must therefore be screened at high concentration in order to detect binding events. Since some issues are associated with high-concentration screening in biochemical assays, biophysical methods are generally employed in fragment screening campaigns. Moreover, these techniques are very sensitive and some of them can give precise information about the binding mode of fragments, which facilitates the mandatory hit-to-lead optimization. One of the main advantages of fragment-based screening is that fragment hits generally exhibit a strong binding with respect to their size, and their subsequent optimization should lead to compounds with better pharmacokinetic properties compared to molecules evolved from HTS hits. In other words, fragments are interesting starting points for drug discovery projects. Besides, the chemical space of low-complexity compounds is very limited in comparison to that of drug-like molecules, and thus easier to explore with a screening library of limited size. Furthermore, the "combinatorial explosion" effect ensures that the resulting combinations of interlinked binding fragments may cover a significant part of "drug-like" chemical space. In parallel to experimental screening, virtual screening techniques, dedicated to fragments or wider compounds, are gaining momentum in order to further reduce the number of compounds to test. This article is a review of the latest news in both experimental and in silico virtual screening in the fragment-based discovery field. Given the specificity of this journal, special attention will be given to fragment library design. 相似文献
3.
Niklas Blomberg David A. Cosgrove Peter W. Kenny Karin Kolmodin 《Journal of computer-aided molecular design》2009,23(8):513-525
Approaches to the design of libraries for fragment screening are illustrated with reference to a 20 k generic fragment screening
library and a 1.2 k generic NMR screening library. Tools and methods for library design that have been developed within AstraZeneca
are described, including Foyfi fingerprints and the Flush program for neighborhood characterization. It will be shown how
Flush and the BigPicker, which selects maximally diverse sets of compounds, are used to apply the Core and Layer method for
library design. Approaches to partitioning libraries into cocktails are also described. 相似文献
4.
Kanhaya Lal Rafael Bermeo Dr. Jonathan Cramer Prof. Dr. Francesca Vasile Prof. Dr. Beat Ernst Dr. Anne Imberty Prof. Dr. Anna Bernardi Dr. Annabelle Varrot Prof. Dr. Laura Belvisi 《Chemistry (Weinheim an der Bergstrasse, Germany)》2021,27(40):10341-10348
Burkholderia cenocepacia is an opportunistic Gram-negative bacterium that causes infections in patients suffering from chronic granulomatous diseases and cystic fibrosis. It displays significant morbidity and mortality due to extreme resistance to almost all clinically useful antibiotics. The bacterial lectin BC2L-C expressed in B. cenocepacia is an interesting drug target involved in bacterial adhesion and subsequent deadly infection to the host. We solved the first high resolution crystal structure of the apo form of the lectin N-terminal domain (BC2L-C-nt) and compared it with the ones complexed with carbohydrate ligands. Virtual screening of a small fragment library identified potential hits predicted to bind in the vicinity of the fucose binding site. A series of biophysical techniques and X-ray crystallographic screening were employed to validate the interaction of the hits with the protein domain. The X-ray structure of BC2L-C-nt complexed with one of the identified active fragments confirmed the ability of the site computationally identified to host drug-like fragments. The fragment affinity could be determined by titration microcalorimetry. These structure-based strategies further provide an opportunity to elaborate the fragments into high affinity anti-adhesive glycomimetics, as therapeutic agents against B. cenocepacia. 相似文献
5.
Nikolaj S. Troelsen Elena Shanina Diego Gonzalez-Romero Daniela Danková Ida S. A. Jensen Katarzyna J. Śniady Faranak Nami Hengxi Zhang Christoph Rademacher Ana Cuenda Charlotte H. Gotfredsen Mads H. Clausen 《Angewandte Chemie (Weinheim an der Bergstrasse, Germany)》2020,132(6):2224-2230
Fragment-based drug discovery (FBDD) is a popular method in academia and the pharmaceutical industry for the discovery of early lead candidates. Despite its wide-spread use, the approach still suffers from laborious screening workflows and a limited diversity in the fragments applied. Presented here is the design, synthesis, and biological evaluation of the first fragment library specifically tailored to tackle both these challenges. The 3F library of 115 fluorinated, Fsp3-rich fragments is shape diverse and natural-product-like with desirable physicochemical properties. The library is perfectly suited for rapid and efficient screening by NMR spectroscopy in a two-stage workflow of 19F NMR and subsequent 1H NMR methods. Hits against four diverse protein targets are widely distributed among the fragment scaffolds in the 3F library and a 67 % validation rate was achieved using secondary assays. This collection is the first synthetic fragment library tailor-made for 19F NMR screening and the results demonstrate that the approach should find broad application in the FBDD community. 相似文献
6.
Sameer Kawatkar Hongming Wang Ryszard Czerminski Diane Joseph-McCarthy 《Journal of computer-aided molecular design》2009,23(8):527-539
Fragment-based drug discovery approaches allow for a greater coverage of chemical space and generally produce high efficiency
ligands. As such, virtual and experimental fragment screening are increasingly being coupled in an effort to identify new
leads for specific therapeutic targets. Fragment docking is employed to create target-focussed subset of compounds for testing
along side generic fragment libraries. The utility of the program Glide with various scoring schemes for fragment docking
is discussed. Fragment docking results for two test cases, prostaglandin D2 synthase and DNA ligase, are presented and compared
to experimental screening data. Self-docking, cross-docking, and enrichment studies are performed. For the enrichment runs,
experimental data exists indicating that the docking decoys in fact do not inhibit the corresponding enzyme being examined.
Results indicate that even for difficult test cases fragment docking can yield enrichments significantly better than random.
Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users. 相似文献
7.
Ross P. Thomas Rachel E. Heap Francesca Zappacosta Emma K. Grant Peter Pogny Stephen Besley David J. Fallon Michael M. Hann David House Nicholas C. O. Tomkinson Jacob T. Bush 《Chemical science》2021,12(36):12098
Methods for rapid identification of chemical tools are essential for the validation of emerging targets and to provide medicinal chemistry starting points for the development of new medicines. Here, we report a screening platform that combines ‘direct-to-biology’ high-throughput chemistry (D2B-HTC) with photoreactive fragments. The platform enabled the rapid synthesis of >1000 PhotoAffinity Bits (HTC-PhABits) in 384-well plates in 24 h and their subsequent screening as crude reaction products with a protein target without purification. Screening the HTC-PhABit library with carbonic anhydrase I (CAI) afforded 7 hits (0.7% hit rate), which were found to covalently crosslink in the Zn2+ binding pocket. A powerful advantage of the D2B-HTC screening platform is the ability to rapidly perform iterative design–make–test cycles, accelerating the development and optimisation of chemical tools and medicinal chemistry starting points with little investment of resource.A photoreactive fragment screening platform employing direct-to-biology high-throughput chemistry (D2B-HTC) for the rapid iterative synthesis and screening of libraries of photoaffinity bits. 相似文献
8.
9.
Nikolaj S. Troelsen Elena Shanina Diego Gonzalez‐Romero Daniela Dankov Ida S. A. Jensen Katarzyna J.
niady Faranak Nami Hengxi Zhang Christoph Rademacher Ana Cuenda Charlotte H. Gotfredsen Mads H. Clausen 《Angewandte Chemie (International ed. in English)》2020,59(6):2204-2210
Fragment‐based drug discovery (FBDD) is a popular method in academia and the pharmaceutical industry for the discovery of early lead candidates. Despite its wide‐spread use, the approach still suffers from laborious screening workflows and a limited diversity in the fragments applied. Presented here is the design, synthesis, and biological evaluation of the first fragment library specifically tailored to tackle both these challenges. The 3F library of 115 fluorinated, Fsp3‐rich fragments is shape diverse and natural‐product‐like with desirable physicochemical properties. The library is perfectly suited for rapid and efficient screening by NMR spectroscopy in a two‐stage workflow of 19F NMR and subsequent 1H NMR methods. Hits against four diverse protein targets are widely distributed among the fragment scaffolds in the 3F library and a 67 % validation rate was achieved using secondary assays. This collection is the first synthetic fragment library tailor‐made for 19F NMR screening and the results demonstrate that the approach should find broad application in the FBDD community. 相似文献
10.
Baurin N Aboul-Ela F Barril X Davis B Drysdale M Dymock B Finch H Fromont C Richardson C Simmonite H Hubbard RE 《Journal of chemical information and computer sciences》2004,44(6):2157-2166
We have designed four generations of a low molecular weight fragment library for use in NMR-based screening against protein targets. The library initially contained 723 fragments which were selected manually from the Available Chemicals Directory. A series of in silico filters and property calculations were developed to automate the selection process, allowing a larger database of 1.79 M available compounds to be searched for a further 357 compounds that were added to the library. A kinase binding pharmacophore was then derived to select 174 kinase-focused fragments. Finally, an additional 61 fragments were selected to increase the number of different pharmacophores represented within the library. All of the fragments added to the library passed quality checks to ensure they were suitable for the screening protocol, with appropriate solubility, purity, chemical stability, and unambiguous NMR spectrum. The successive generations of libraries have been characterized through analysis of structural properties (molecular weight, lipophilicity, polar surface area, number of rotatable bonds, and hydrogen-bonding potential) and by analyzing their pharmacophoric complexity. These calculations have been used to compare the fragment libraries with a drug-like reference set of compounds and a set of molecules that bind to protein active sites. In addition, an analysis of the overall results of screening the library against the ATP binding site of two protein targets (HSP90 and CDK2) reveals different patterns of fragment binding, demonstrating that the approach can find selective compounds that discriminate between related binding sites. 相似文献
11.
Richard Law Oliver Barker John J. Barker Thomas Hesterkamp Robert Godemann Ole Andersen Tara Fryatt Steve Courtney Dave Hallett Mark Whittaker 《Journal of computer-aided molecular design》2009,23(8):459-473
Fragment-based drug discovery (FBDD) represents a change in strategy from the screening of molecules with higher molecular
weights and physical properties more akin to fully drug-like compounds, to the screening of smaller, less complex molecules.
This is because it has been recognised that fragment hit molecules can be efficiently grown and optimised into leads, particularly
after the binding mode to the target protein has been first determined by 3D structural elucidation, e.g. by NMR or X-ray
crystallography. Several studies have shown that medicinal chemistry optimisation of an already drug-like hit or lead compound
can result in a final compound with too high molecular weight and lipophilicity. The evolution of a lower molecular weight
fragment hit therefore represents an attractive alternative approach to optimisation as it allows better control of compound
properties. Computational chemistry can play an important role both prior to a fragment screen, in producing a target focussed
fragment library, and post-screening in the evolution of a drug-like molecule from a fragment hit, both with and without the
available fragment-target co-complex structure. We will review many of the current developments in the area and illustrate
with some recent examples from successful FBDD discovery projects that we have conducted. 相似文献
12.
Fragment-based drug discovery (FBDD) has become a new strategy for drug discovery where lead compounds are evolved from small molecules. These fragments form low affinity interactions (dissociation constant (K (D))?=?mM?-?μM) with protein targets, which require fragment screening methods of sufficient sensitivity. Weak affinity chromatography (WAC) is a promising new technology for fragment screening based on selective retention of fragments by a drug target. Kinases are a major pharmaceutical target, and FBDD has been successfully applied to several of these targets. In this work, we have demonstrated the potential to use WAC in combination with mass spectrometry (MS) detection for fragment screening of a kinase target-cyclin G-associated kinase (GAK). One hundred seventy fragments were selected for WAC screening by virtual screening of a commercial fragment library against the ATP-binding site of five different proteins. GAK protein was immobilized on a capillary HPLC column, and compound binding was characterized by frontal affinity chromatography. Compounds were screened in sets of 13 or 14, in combination with MS detection for enhanced throughput. Seventy-eight fragments (46?%) with K (D)?200?μM were detected, including a few highly efficient GAK binders (K (D) of 2?μM; ligand efficiency?=?0.51). Of special interest is that chiral screening by WAC may be possible, as two stereoisomeric fragments, which both contained one chiral center, demonstrated twin peaks. This ability, in combination with the robustness, sensitivity, and simplicity of WAC makes it a new method for fragment screening of considerable potential. 相似文献
13.
Hsieh JH Wang XS Teotico D Golbraikh A Tropsha A 《Journal of computer-aided molecular design》2008,22(9):593-609
14.
Abstract
Thymidine monophosphate kinase (TMPKmt) is an essential enzyme for nucleotide metabolism in Mycobacterium tuberculosis, and thus an attractive target for novel antituberculosis agents. In this work, we have explored the chemical space around the 2′,3′-bicyclic thymidine nucleus by designing and in silico screening of a virtual focused library selected via structure based methods to identify more potent analogs endowed with favorable ADME-related properties. In all the library members we have exchanged the ribose ring of the template with a cyclopentane moiety that is less prone to enzymatic degradation. In addition, we have replaced the six-membered 2′,3′-ring by a number of five-membered and six-membered heterocyclic rings containing alternative proton donor and acceptor groups, to exploit the interaction with the carboxylate groups of Asp9 and Asp163 as well as with several cationic residues present in the vicinity of the TMPKmt binding site. The three-dimensional structure of the TMPKmt complexed with 5-hydroxymethyl-dUMP, an analog of dTMP, was employed to develop a QSAR model, to parameterize a scoring function specific for the TMPKmt target and to select analogues which display the highest predicted binding to the target. As a result, we identified a small highly focused combinatorial subset of bicyclic thymidine analogues as virtual hits that are predicted to inhibit the mycobacterial TMPK in the submicromolar concentration range and to display favorable ADME-related properties. 相似文献15.
Wartchow CA Podlaski F Li S Rowan K Zhang X Mark D Huang KS 《Journal of computer-aided molecular design》2011,25(7):669-676
Biosensor-based fragment screening is a valuable tool in the drug discovery process. This method is advantageous over many
biochemical methods because primary hits can be distinguished from non-specific or non-ideal interactions by examining binding
profiles and responses, resulting in reduced false-positive rates. Biolayer interferometry (BLI), a technique that measures
changes in an interference pattern generated from visible light reflected from an optical layer and a biolayer containing
proteins of interest, is a relatively new method for monitoring small molecule interactions. The BLI format is based on a
disposable sensor that is immersed in 96-well or 384-well plates. BLI has been validated for small molecule detection and
fragment screening with model systems and well-characterized targets where affinity constants and binding profiles are generally
similar to those obtained with surface plasmon resonsance (SPR). Screens with challenging targets involved in protein–protein
interactions including BCL-2, JNK1, and eIF4E were performed with a fragment library of 6,500 compounds, and hit rates were
compared for these targets. For eIF4E, a protein containing a PPI site and a nucleotide binding site, results from a BLI fragment
screen were compared to results obtained in biochemical HTS screens. Overlapping hits were observed for the PPI site, and
hits unique to the BLI screen were identified. Hit assessments with SPR and BLI are described. 相似文献
16.
SAMPL3 fragment based virtual screening challenge provides a valuable opportunity for researchers to test their programs, methods and screening protocols in a blind testing environment. We participated in SAMPL3 challenge and evaluated our virtual fragment screening protocol, which involves RosettaLigand as the core component by screening a 500 fragments Maybridge library against bovine pancreatic trypsin. Our study reaffirmed that the real test for any virtual screening approach would be in a blind testing environment. The analyses presented in this paper also showed that virtual screening performance can be improved, if a set of known active compounds is available and parameters and methods that yield better enrichment are selected. Our study also highlighted that to achieve accurate orientation and conformation of ligands within a binding site, selecting an appropriate method to calculate partial charges is important. Another finding is that using multiple receptor ensembles in docking does not always yield better enrichment than individual receptors. On the basis of our results and retrospective analyses from SAMPL3 fragment screening challenge we anticipate that chances of success in a fragment screening process could be increased significantly with careful selection of receptor structures, protein flexibility, sufficient conformational sampling within binding pocket and accurate assignment of ligand and protein partial charges. 相似文献
17.
Colony-stimulating factor 1 receptor is a type III receptor protein tyrosine kinase belonging to PDGFR family. CSF1R signaling is essential for differentiation, proliferation and survival of macrophages. Aberrant expression of CSF1R appears to be an attractive target in several cancer types. Higher expression of CSF1R ligands correlates to tumor progression. CSF1R inhibitors have been shown to suppress cancers. We have attempted an in silico fragment derived drug discovery approach by screening ˜25,000 in-house compounds as potential CSF1R inhibitors. Using FBDD approach we have identified six diverse fragments that exhibit affinity towards hinge region of CSF1R. Some of the fragments 5-nitroindole and 7-azaindole and their derivatives were synthesized for further evaluation. The in silico and in vitro enzyme activity studies reveal moderate inhibition of CSF1R kinase activity by 5-nitroindole and good inhibition by 7-azaindole fragments. Bio and chemiinformatics studies have shown that 7-azaindole compounds have better membrane permeability and enzyme inhibition properties. Molecular docking studies show that the amino acid residues 664–666 in the hinge region of the cytosolic domain of CSF1R to be the preferred region of binding for nitroindole and azaindole derivatives. Further optimization and biological analysis would identify these fragments as potential and promising leads as CSF1R inhibitors. 相似文献
18.
Bau S Schracke N Kränzle M Wu H Stähler PF Hoheisel JD Beier M Summerer D 《Analytical and bioanalytical chemistry》2009,393(1):171-175
We report a flexible method for selective capture of sequence fragments from complex, eukaryotic genome libraries for next-generation
sequencing based on hybridization to DNA microarrays. Using microfluidic array architecture and integrated hardware, the process
is amenable to complete automation and does not introduce amplification steps into the standard library preparation workflow,
thereby avoiding bias of sequence distribution and fragment lengths. We captured a discontiguous human genomic target region
of 185 kb using a tiling design with 50mer probes. Analysis by high-throughput sequencing using an Illumina/Solexa 1G Genome
Analyzer revealed 2150-fold enrichment with mean per base coverage between 4.6 and 107.5-fold for the individual target regions.
This method represents a flexible and cost-effective approach for large-scale resequencing of complex genomes.
Electronic supplementary material The online version of this article (doi:) contains supplementary material, which is available to authorized users.
Stephan Bau and Nadine Schracke contributed equally to this work. 相似文献
19.
Pollack SJ Beyer KS Lock C Müller I Sheppard D Lipkin M Hardick D Blurton P Leonard PM Hubbard PA Todd D Richardson CM Ahrens T Baader M Hafenbradl DO Hilyard K Bürli RW 《Journal of computer-aided molecular design》2011,25(7):677-687
The stress-activated kinase p38α was used to evaluate a fragment-based drug discovery approach using the BioFocus fragment library. Compounds were screened by surface plasmon resonance (SPR) on a Biacore(?) T100 against p38α and two selectivity targets. A sub-set of our library was the focus of detailed follow-up analyses that included hit confirmation, affinity determination on 24 confirmed, selective hits and competition assays of these hits with respect to a known ATP binding site inhibitor. In addition, functional activity against p38α was assessed in a biochemical assay using a mobility shift platform (LC3000, Caliper LifeSciences). A selection of fragments was also evaluated using fluorescence lifetime (FLEXYTE(?)) and microscale thermophoresis (Nanotemper) technologies. A good correlation between the data for the different assays was found. Crystal structures were solved for four of the small molecules complexed to p38α. Interestingly, as determined both by X-ray analysis and SPR competition experiments, three of the complexes involved the fragment at the ATP binding site, while the fourth compound bound in a distal site that may offer potential as a novel drug target site. A first round of optimization around the remotely bound fragment has led to the identification of a series of triazole-containing compounds. This approach could form the basis for developing novel and active p38α inhibitors. More broadly, it illustrates the power of combining a range of biophysical and biochemical techniques to the discovery of fragments that facilitate the development of novel modulators of kinase and other drug targets. 相似文献
20.
Exploring Weak Ligand–Protein Interactions by Long‐Lived NMR States: Improved Contrast in Fragment‐Based Drug Screening 下载免费PDF全文
Roberto Buratto Daniele Mammoli Dr. Elisabetta Chiarparin Dr. Glyn Williams Prof. Geoffrey Bodenhausen 《Angewandte Chemie (International ed. in English)》2014,53(42):11376-11380
Ligands that have an affinity for protein targets can be screened very effectively by exploiting favorable properties of long‐lived states (LLS) in NMR spectroscopy. In this work, we describe the use of LLS for competitive binding experiments to measure accurate dissociation constants of fragments that bind weakly to the ATP binding site of the N‐terminal ATPase domain of heat shock protein 90 (Hsp90), a therapeutic target for cancer treatment. The LLS approach allows one to characterize ligands with an exceptionally wide range of affinities, since it can be used for ligand concentrations [L] that are several orders of magnitude smaller than the dissociation constants KD. This property makes the LLS method particularly attractive for the initial steps of fragment‐based drug screening, where small molecular fragments that bind weakly to a target protein must be identified, which is a difficult task for many other biophysical methods. 相似文献